BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2010 related articles for article (PubMed ID: 25946689)

  • 1. LONG-TERM OUTCOMES OF 23-GAUGE PARS PLANA VITRECTOMY WITH INTERNAL LIMITING MEMBRANE PEELING AND GAS TAMPONADE FOR MYOPIC TRACTION MACULOPATHY: A Prospective Study.
    Figueroa MS; Ruiz-Moreno JM; Gonzalez del Valle F; Govetto A; de la Vega C; Plascencia RN; Contreras I; Medina JL
    Retina; 2015 Sep; 35(9):1836-43. PubMed ID: 25946689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitrectomy and internal limiting membrane peeling with perfluoropropane tamponade or balanced saline solution for myopic foveoschisis.
    Zheng B; Chen Y; Chen Y; Zhao Z; Zhang Z; Zheng J; You Y; Wang Q; Shen L
    Retina; 2011 Apr; 31(4):692-701. PubMed ID: 21836401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitrectomy with or without internal limiting membrane peeling for each stage of myopic traction maculopathy.
    Taniuchi S; Hirakata A; Itoh Y; Hirota K; Inoue M
    Retina; 2013; 33(10):2018-25. PubMed ID: 23975004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microincision vitrectomy surgery for myopic foveoschisis.
    Hwang JU; Joe SG; Lee JY; Kim JG; Yoon YH
    Br J Ophthalmol; 2013 Jul; 97(7):879-84. PubMed ID: 23603757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of microscope-integrated intraoperative optical coherence tomography-guided center-sparing internal limiting membrane peeling for myopic traction maculopathy: a novel technique.
    Kumar A; Ravani R; Mehta A; Simakurthy S; Dhull C
    Int Ophthalmol; 2018 Aug; 38(4):1689-1696. PubMed ID: 28676991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fovea-sparing internal limiting membrane peeling for myopic traction maculopathy.
    Shimada N; Sugamoto Y; Ogawa M; Takase H; Ohno-Matsui K
    Am J Ophthalmol; 2012 Oct; 154(4):693-701. PubMed ID: 22835515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors correlated with postoperative visual acuity after vitrectomy and internal limiting membrane peeling for myopic foveoschisis.
    Kumagai K; Furukawa M; Ogino N; Larson E
    Retina; 2010 Jun; 30(6):874-80. PubMed ID: 20094010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fovea-Sparing versus Standard Internal Limiting Membrane Peeling for Myopic Traction Maculopathy: A Study of 102 Consecutive Cases.
    Shiraki N; Wakabayashi T; Ikuno Y; Matsumura N; Sato S; Sakaguchi H; Nishida K
    Ophthalmol Retina; 2020 Dec; 4(12):1170-1180. PubMed ID: 32470651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PARS PLANA VITRECTOMY AND WIDE INTERNAL LIMITING MEMBRANE PEELING WITH PERFLUOROPROPANE TAMPONADE FOR HIGHLY MYOPIC FOVEOSCHISIS-ASSOCIATED MACULAR HOLE.
    Zhang Z; Wei Y; Jiang X; Zhang S
    Retina; 2017 Feb; 37(2):274-282. PubMed ID: 27429390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of non-fovea-sparing ILM peeling for symptomatic myopic foveoschisis with and without macular hole.
    Al-Badawi AH; Abdelhakim MASE; Macky TA; Mortada HA
    Br J Ophthalmol; 2019 Feb; 103(2):257-263. PubMed ID: 29712637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macular hole repair by vitrectomy and internal limiting membrane peeling in highly myopic eyes.
    Chuang LH; Chen YP; Wang NK; Yeung L; Chen KJ; Hwang YS; Wu WC; Chen TL; Lai CC
    Retina; 2014 Oct; 34(10):2021-7. PubMed ID: 24859476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fovea-sparing internal limiting membrane peeling versus complete internal limiting membrane peeling for myopic traction maculopathy.
    Iwasaki M; Miyamoto H; Okushiba U; Imaizumi H
    Jpn J Ophthalmol; 2020 Jan; 64(1):13-21. PubMed ID: 31686266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitrectomy and internal limiting membrane peeling with and without gas tamponade for myopic foveoschisis.
    Kim KS; Lee SB; Lee WK
    Am J Ophthalmol; 2012 Feb; 153(2):320-326.e1. PubMed ID: 21982957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitrectomy and internal limiting membrane peeling without gas tamponade for myopic foveoschisis.
    Lim SJ; Kwon YH; Kim SH; You YS; Kwon OW
    Graefes Arch Clin Exp Ophthalmol; 2012 Nov; 250(11):1573-7. PubMed ID: 22411130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vitrectomy without internal limiting membrane peeling associated with gas tamponade for treatment of foveoschisis in pathologic myopia].
    Zhang YP; Xue AQ; Wang YQ; Yan WT; Song ZM
    Zhonghua Yan Ke Za Zhi; 2011 Jun; 47(6):497-503. PubMed ID: 21914263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VITRECTOMY WITH INTERNAL LIMITING MEMBRANE PEELING AND AIR TAMPONADE FOR MYOPIC FOVEOSCHISIS.
    Rizzo S; Giansanti F; Finocchio L; Caporossi T; Barca F; Bacherini D; Cocci G; Vannucchi M; Tartaro R; Virgili G
    Retina; 2019 Nov; 39(11):2125-2131. PubMed ID: 30015762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for development of full-thickness macular holes after pars plana vitrectomy for myopic foveoschisis.
    Gao X; Ikuno Y; Fujimoto S; Nishida K
    Am J Ophthalmol; 2013 Jun; 155(6):1021-1027.e1. PubMed ID: 23522356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VITRECTOMY WITHOUT INNER LIMITING MEMBRANE PEELING FOR MACULAR RETINOSCHISIS IN HIGHLY MYOPIC EYES.
    Qi Y; Duan AL; Meng X; Wang N
    Retina; 2016 May; 36(5):953-6. PubMed ID: 26529553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reoperation for persistent myopic foveoschisis after primary vitrectomy.
    Sayanagi K; Ikuno Y; Tano Y
    Am J Ophthalmol; 2006 Feb; 141(2):414-7. PubMed ID: 16458717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative anatomical and functional outcomes of different stages of high myopia macular hole.
    Shao Q; Xia H; Heussen FM; Ouyang Y; Sun X; Fan Y
    BMC Ophthalmol; 2015 Aug; 15():93. PubMed ID: 26250415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 101.